7-101218171-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_006349.3(ZNHIT1):c.-25T>C variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.229 in 1,610,718 control chromosomes in the GnomAD database, including 42,781 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.23 ( 4141 hom., cov: 32)
Exomes 𝑓: 0.23 ( 38640 hom. )
Consequence
ZNHIT1
NM_006349.3 5_prime_UTR
NM_006349.3 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.42
Genes affected
ZNHIT1 (HGNC:21688): (zinc finger HIT-type containing 1) Predicted to enable histone deacetylase binding activity and nucleosome binding activity. Predicted to be involved in histone exchange. Predicted to act upstream of or within several processes, including negative regulation of G0 to G1 transition; negative regulation of transcription by RNA polymerase II; and regulation of histone deacetylation. Located in nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022]
PLOD3 (HGNC:9083): (procollagen-lysine,2-oxoglutarate 5-dioxygenase 3) The protein encoded by this gene is a membrane-bound homodimeric enzyme that is localized to the cisternae of the rough endoplasmic reticulum. The enzyme (cofactors iron and ascorbate) catalyzes the hydroxylation of lysyl residues in collagen-like peptides. The resultant hydroxylysyl groups are attachment sites for carbohydrates in collagen and thus are critical for the stability of intermolecular crosslinks. Some patients with Ehlers-Danlos syndrome type VIB have deficiencies in lysyl hydroxylase activity. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 7-101218171-T-C is Benign according to our data. Variant chr7-101218171-T-C is described in ClinVar as [Benign]. Clinvar id is 1267931.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.27 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNHIT1 | NM_006349.3 | c.-25T>C | 5_prime_UTR_variant | 1/5 | ENST00000305105.3 | NP_006340.1 | ||
ZNHIT1 | XM_011515739.3 | c.-248T>C | 5_prime_UTR_variant | 1/5 | XP_011514041.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNHIT1 | ENST00000305105 | c.-25T>C | 5_prime_UTR_variant | 1/5 | 1 | NM_006349.3 | ENSP00000304593.2 |
Frequencies
GnomAD3 genomes AF: 0.232 AC: 35253AN: 152088Hom.: 4133 Cov.: 32
GnomAD3 genomes
AF:
AC:
35253
AN:
152088
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.228 AC: 56865AN: 249470Hom.: 6649 AF XY: 0.233 AC XY: 31401AN XY: 135050
GnomAD3 exomes
AF:
AC:
56865
AN:
249470
Hom.:
AF XY:
AC XY:
31401
AN XY:
135050
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.229 AC: 333694AN: 1458512Hom.: 38640 Cov.: 33 AF XY: 0.230 AC XY: 166859AN XY: 725336
GnomAD4 exome
AF:
AC:
333694
AN:
1458512
Hom.:
Cov.:
33
AF XY:
AC XY:
166859
AN XY:
725336
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.232 AC: 35285AN: 152206Hom.: 4141 Cov.: 32 AF XY: 0.232 AC XY: 17230AN XY: 74400
GnomAD4 genome
AF:
AC:
35285
AN:
152206
Hom.:
Cov.:
32
AF XY:
AC XY:
17230
AN XY:
74400
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
873
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 19, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at